Rockefeller Capital Management L.P. 9 Meters Biopharma, Inc. Transaction History

Rockefeller Capital Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$0.21 - $0.32 $4,200 - $6,400	20,000 New	20,000 $4,000
Q4 2020 Feb 12, 2021	SELL	$0.65 - $1.11 $65 - $111	-100 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$0.48 - $0.84 $48 - $84	100 New	100 $0

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.